James A. Robinson Jr. - Jul 25, 2023 Form 4/A - Amendment Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Jul 25, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/28/2023, 06:05 PM
Date Of Original Report
Jul 27, 2023
Previous filing
Dec 1, 2022
Next filing
Sep 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Award $0 +20K $0.00 20K Jul 25, 2023 Ordinary Shares 20K $8.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option vest in equal quarterly installments over 12 months